![Alex David Iguaran on X: "CHA2DS2-VASc , escala para estimar estimar el riesgo de accidente cerebrovascular en pacientes con fibrilación auricular #RotUrg https://t.co/11GnCO9ffQ" / X Alex David Iguaran on X: "CHA2DS2-VASc , escala para estimar estimar el riesgo de accidente cerebrovascular en pacientes con fibrilación auricular #RotUrg https://t.co/11GnCO9ffQ" / X](https://pbs.twimg.com/media/DTJ3Tg6WAAUEZ6Y.jpg)
Alex David Iguaran on X: "CHA2DS2-VASc , escala para estimar estimar el riesgo de accidente cerebrovascular en pacientes con fibrilación auricular #RotUrg https://t.co/11GnCO9ffQ" / X
![Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2015/09/Table-2.-The-2009-Birmingham-Scheme-%E2%80%93-CHA2DS2-VASc-Scoring-System-240x300.png)
Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology
![Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk - ISTH Congress Abstracts Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2021/06/1080_results_1.png)
Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk - ISTH Congress Abstracts
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/701606b6f7d086fe6e65e93f9961d5ae9ad858bb/2-Table1-1.png)
PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/f0c76a4b-279a-46cf-abea-39dfbbb036a3/e003476fig02.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download](https://images.slideplayer.com/30/9547440/slides/slide_2.jpg)
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download
![PDF] Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. | Semantic Scholar PDF] Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dd8fdb74de7e9a0a2ee3e916f24173b2cc49017a/2-Table1-1.png)
PDF] Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. | Semantic Scholar
![Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer | JACC: CardioOncology Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer | JACC: CardioOncology](https://www.jacc.org/cms/asset/1b64d178-6eaa-4043-bf00-61ba30481443/fx1.jpg)